Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Nov 6, 2025
Oncology program advancing with data expected in the fourth quarter 2025
BEACON-IPF close out activities to be completed in the fourth quarter 2025
Read more at globenewswire.com1.24
+0.01 (+0.81%)
Find more stocks in the Stock Screener
PLRX Latest News and Analysis
